Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Estimating the Risk-Based Value of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world?

medRxiv(2025)10.1101/2025.10.02.25337195Source: DataRank Database

Estimating the Risk-Based Value of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world? is a research paper published in medRxiv (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: greenTopics (10)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Samuel B. Weidner ORCID,Ching-Hsuan Lin,David M. Kent ORCID,Natalia Olchanski ORCID

Live enrichment

PubMed:41358281 OpenAlex:https://openalex.org/W4414839241

greenLicense: https://www.medrxiv.org/about/FAQ#license

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2025/10/05/2025.10.02.25337195.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2025.10.02.25337195

repositoryhttps://doi.org/10.1101/2025.10.02.25337195

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41358281

Fields of Study

Health Systems, Economic Evaluations, Quality of LifeDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Education

Keywords

Diabetes mellitusPrioritizationValue (mathematics)Clinical trialReal world dataRisk assessmentDiabetes treatment